Market Research Report

Global Cardiac AI Monitoring and Diagnostics Market Research Report: Forecast (2024-2030)

Cardiac AI Monitoring and Diagnostics Market Report - By Product (Software, Hardware), By Type (Cardiac Diagnostics, [Cardiac Imaging, Electrocardiography-Based (ECG-Based) Diagnos...tics, Others (Blood Biomarker Analysis, Cardiac Stress Testing, etc.)], Cardiac Monitoring), By Indication, (Hypertension (High Blood Pressure), Coronary Artery Disease (CAD), Arrhythmias, Cardiomyopathies, Others (Valvular Heart Disease, Peripheral Artery Disease (PAD), etc.)), By End-User (Hospitals, Diagnostic Centers, Specialty Cardiology Clinics, Ambulatory Surgical Centers), Others Read more

  • Healthcare
  • Apr 2024
  • 197
  • PDF, Excel, PPT

Market Definition

Cardiac AI (Artificial Intelligence) Monitoring and Diagnostics uses artificial intelligence and machine learning technologies to monitor, diagnose, and analyze the condition of patients suffering from cardiac diseases. It involves the application of advanced algorithms and software to process and interpret data from various cardiac monitoring devices and medical tests, such as electrocardiograms (ECGs or EKGs), echocardiograms, Holter monitors, and wearable heart rate monitors. It reduces the time spent manually analyzing all the data received for cardiac diagnostics and monitoring devices.

Market Insights & Analysis: Global Cardiac AI Monitoring and Diagnostics Market (2024-30):

The Global Cardiac AI Monitoring and Diagnostics Market size is estimated to grow at a CAGR of around 25.6% during the forecast period, i.e., 2024–30. The market has been witnessing significant growth owing to factors such as the rising incidence of cardiovascular disease. One of the causes of the deterioration of cardiac health and the increased prevalence of risk factors like cardiovascular diseases (CVDs), complex lesions, diabetes, etc., is the rising geriatric population across the globe and the sedentary lifestyle of consumers.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-30
CAGR (2024-2030) 25.6%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled HeartVista, Inc., Siemens Healthineers AG, RSIP Vision, Ultromics Limited., Tempus Labs, Inc., Cardiologs Technologies, Cleerly, Inc., AliveCor, Inc., Aidoc Medical Ltd., Boston Scientific Corporation, CathWork Inc., HeartFlow, Inc., iRhythm Technologies, Inc., Nano-x Imaging Ltd., etc.
Unit Denominations USD Million/Billion

 

In addition to the rising instances of cardiovascular diseases (CVD), the deaths related to them have also been increasing. For instance,

  • According to the World Health Organization (WHO) report 2019, cardiovascular diseases were among the leading causes of death globally and have been estimated to have caused over 17.9 million deaths worldwide in 2019, accounting for more than 32% of all fatalities.

As a result, the unprecedented rise in cardiovascular disease incidence boosted the need for early diagnosis and treatment. Also, the major deaths linked to CVD were associated with the lack of proper diagnosis solutions, which would allow the detection of the disease, along with the prediction of proper treatment solutions. Hence, a need for integrating better software to allow early detection of abnormalities in heart rhythm arose, which has significantly boosted market growth & expansion.


Global Cardiac AI Monitoring and Diagnostics Market Research Report: Forecast (2024-2030)

Global Cardiac AI Monitoring and Diagnostics Market Driver:

Rising Incidence of Coronary Artery Diseases – With the rising incidence of coronary artery diseases worldwide, especially across Asia-Pacific, and Europe, owing to the rising adoption of unhealthy and sedentary lifestyles among consumers, demand for monitoring and diagnosis services has been increasing significantly across the globe. Additionally, other health factors, including physical inactivity, being overweight, unhealthy eating, and smoking tobacco, have been causing the deposition of plaque and cholesterol in blood vessels, causing cardiovascular diseases (CVD). For instance,

  • According to the British Heart Foundation, in 2022, globally, 1 in every 14 people was living with coronary heart disease, either linked to the heart or circulatory vessels.

Consequently, as the number of patients suffering from CVD has been increasing, healthcare professionals have started inclining toward AI software and services over the years. The inclination toward AI software in cardiovascular diagnosis and monitoring has been attributed to the ease of processing large amounts of data generated from these diagnostic devices within a minimum amount of time. Henceforth, with the rising number of heart diseases, coupled with growing health facilities adopting AI software in the cardiology segment across regions like North America, Asia Pacific, etc., the market would witness considerable growth & expansion during the forecast period.

Global Cardiac AI Monitoring and Diagnostics Market Opportunity:

Increasing Focus on the Development of AI-Enabled Implantable Cardiac Monitors – In recent years, several companies in the medical device segment have started focusing on the development of implantable cardiac monitors, which are operated through AI software. Observing the benefits of AI algorithms in healthcare setups, which have allowed the easy interpretation of cardiac diagnostics and monitoring results, companies are now focusing on integrating them with implantable monitors. For instance,

  • In 2023, BIOTRONIK, a pioneer in implantable medical devices, launched the BIOMONITOR IV implantable cardiac monitor (ICM). It is an implantable cardiac monitor enhanced with artificial intelligence, which harnesses AI and sophisticated detection algorithms to minimize false positive arrhythmia alerts.

These monitors are designed to reduce the detection of any false positive results for arrhythmia conditions, which would allow physicians to map more accurate, proactive, and patient-centric treatment solutions for patients. Hence, as companies come up with advanced AI-enabled implantable cardiac monitors, it represents a significant advancement in cardiac care. Thus, as their adoption increases among healthcare professionals, it would create a great opportunity for the growth & development of the market in the coming years.

Global Cardiac AI Monitoring and Diagnostics Market Challenge:

Issues Related to the Data Breaches of AI Models to Hamper Market Growth – Due to issues related to the reliability of AI models, healthcare professionals across the globe are hesitant about the adoption of AI algorithms. The major concern linked to AI adoption included increasing data breach cases across the healthcare sector globally. As the data included in AI-healthcare models includes highly sensitive Personally Identifiable Information (PII) of consumers, their breaches have resulted in the leak of medical history, payment-related information, and identity information of all the patients. For instance,

  • In 2022, according to the Health Sector Cybersecurity Coordination Center, the number of ransomware attacks across healthcare health promotion hospitals in the US increased from 560 in 2020 to 1203 in 2021 across the US.

These attacks have been increasing significantly over the past few years, and the ransom demand has also been growing in parallel. Therefore, the increasing data breach efforts have led to preventing healthcare professionals from adopting AI software in healthcare settings, which is projected to continue as a challenge for the industry in the coming years as well.

Global Cardiac AI Monitoring and Diagnostics Market Trend:

Introduction of AI-based Home Cardiac Monitors Gaining Traction – The introduction of AI-based home cardiac monitors gained significant popularity among customers. Home-based cardiac monitors have been highly preferred by patients across homecare settings, as they allow them to detect any irregularities or changes in heart rhythm from the comfort of their homes. Also, the timely detection of unusual cardiac conditions enabled timely intervention and improved outcomes. Further, observing this improved preference for AI-based home cardiac monitors, companies like Tricog, Omron Healthcare, Teladoc Health, etc., started focusing on the research and development of advanced and improved home monitors. For instance,

  • In 2023, OMRON Healthcare India, a prominent player in-home healthcare monitoring, has partnered with Tricog, a leading heart health AI company, to enter the remote home heart monitoring and management segment in India. They planned to launch TriCare, a platform that combines OMRON's monitoring devices with Tricog's AI for enhanced cardiovascular disease management in the country.

Therefore, AI-based home cardiac monitors are projected to trend in the market in the coming years as well, with improvements in the offerings by companies. In addition, these devices would provide real-time feedback and alerts to users, which would further augment the size & volume of the market in the coming years.

Global Cardiac AI Monitoring and Diagnostics Market (2024-30): Segmentation Analysis

The Global Cardiac AI Monitoring and Diagnostics Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2024–2030 at the global level. According to the analysis, the market has been further classified as:

Based on Type:

  • Cardiac Diagnostics
    • Cardiac Imaging
    • Electrocardiography-Based (ECG-Based) Diagnostics
    • Others (Blood Biomarker Analysis, Cardiac Stress Testing, etc.)
  • Cardiac Monitoring

Cardiac diagnostics has been dominating the Global Cardiac AI Monitoring and Diagnostics Market over the past few years. It has been attributed to its comprehensive evaluation, which allows one to precisely pinpoint the specific cardiac condition, thereby facilitating tailored treatment and management strategies. Further, the gradual incorporation of artificial intelligence (AI) into cardiac diagnostics has ensured the utilization of AI algorithms and methodologies to refine the diagnostic procedure. This integration has been responsible for improving precision, streamlining processes, and broadening accessibility, which further empowers healthcare professionals to deliver optimal patient care.

In addition, in recent years, there have been increased efforts by companies like Philips, Medicalgorithmics, etc., to provide artificial intelligence software and solutions with cardiac diagnostic devices. For instance,

  • In 2023, Medicalgorithmics, a global medtech firm, partnered with German medical equipment provider Livetec Ingenieurbüro GmbH to deliver advanced AI solutions for cardiac diagnostics. The collaboration involves integrating Medicalgorithmics' software with Livetec's ECG monitoring devices and expanding their AI-based software integration with international partners' ECG patch recorders.

Hence, as the provision of AI software integrated with diagnostic devices increases in the coming years, it will support the growth & expansion of the Cardiac AI Monitoring and Diagnostics Industry in the coming years as well.

Based on End User:

  • Hospitals
  • Diagnostic Centres
  • Specialty Cardiology Clinics
  • Ambulatory Surgical Centres

Among them, the hospital segment dominated the Global Cardiac AI Monitoring and Diagnostics Market, claiming the majority of the market share. This dominance is rooted in the rising number of cardiac-related hospital admissions, as more people seek treatment for various forms of cardiac disorders at both government and private healthcare facilities across the globe. In addition, governments across countries like India, the US, China, etc., have recently started investing in the development of new hospitals offering cardiac care services. For instance,

  • In 2022, the Indian Government approved a new multi-specialty hospital within the Anusya Leprosy campus in Vadodara, which has a budget of USD 2.7 million and will offer cutting-edge cardiac care services.

As new hospitals offering cardiac-care services increase, the demand for related software and services, including cardiac AI monitoring and diagnostics software would also amplify. Therefore, hospitals are estimated to hold a major market share in the market in the coming years as well.

Global Cardiac AI Monitoring and Diagnostics Market (2024-30): Regional Projections

Geographically, the Global Cardiac AI Monitoring and Diagnostics Market expands across:

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Among all of them, North America acquired the largest market share in the Global Cardiac AI Monitoring and Diagnostics Market. This supremacy is attributed to several key factors, including the presence of a well-established and technologically advanced healthcare infrastructure, along with a robust digital adoption culture. In addition, the companies present across the North American region have been largely focusing on the research & development of new AI algorithms and gaining FDA approvals to boost the provision of better healthcare services to cardiac patients. For instance,

  • In 2023, Viz.ai's Hypertrophic Cardiomyopathy (HCM) received FDA approval, which marks a new category for cardiovascular machine-learning notification software. This technology can detect and diagnose suspected HCM in patients earlier by scanning images from various healthcare sources.

Hence, with the increasing approvals for AI software for different cardiac indications, their application areas are enhanced, which would further propel their usage in the coming years as well.

Global Cardiac AI Monitoring and Diagnostics Industry Recent Development:

  • 2023: Ultromics Limited, introduced EchoGo® Heart Failure, an AI solution for echocardiography, which has achieved clearance from the US Food and Drug Administration (FDA). EchoGo® Heart Failure is an AI-powered platform designed for precise identification of heart failure with preserved ejection fraction (HFpEF).
  • 2022: iRhythm Technologies, Inc., received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System designed for the Zio Watch. Developed in partnership with Verily, an Alphabet precision health company, the ZEUS System combines advanced deep learning algorithms with a trusted cardiac arrhythmia service.

Gain a Competitive Edge with Our Global Cardiac AI Monitoring and Diagnostics Market Report

  1. Global Cardiac AI Monitoring and Diagnostics Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of market dynamics & make informed decisions.
  2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
  3. Global Cardiac AI Monitoring and Diagnostics Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

Frequently Asked Questions

   A. The Cardiac AI Monitoring and Diagnostics Market is expected to grow at a compound annual growth rate (CAGR) of around 25.6% over the forecast period.

   A. The rising incidence of coronary artery diseases is expected to drive the Cardiac AI Monitoring and Diagnostics Market during 2024-30.

   A. The top companies in the Cardiac AI Monitoring and Diagnostics Market are HeartVista, Inc., Siemens Healthineers AG, RSIP Vision, Ultromics Limited., Tempus Labs, Inc., Cardiologs Technologies, Cleerly, Inc., AliveCor, Inc., Aidoc Medical Ltd., Boston Scientific Corporation, CathWork Inc., HeartFlow, Inc., iRhythm Technologies, Inc., Nano-x Imaging Ltd., and others.

   A. Cardiac Diagnostics held the largest share of the Cardiac AI Monitoring and Diagnostics Market.

   A. North America would present growth prospects in the Cardiac AI Monitoring and Diagnostics Market during 2024-30.

   A. The introduction of AI-based home cardiac monitors is the key trend shaping the growth of the Cardiac AI Monitoring and Diagnostics Market.

   A. The increasing focus on the development of AI-enabled implantable cardiac monitors is the growth opportunity driving the Cardiac AI Monitoring and Diagnostics Market.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Cardiac AI Monitoring and Diagnostics Market Clinical Trial Analysis
  5. Global Cardiac AI Monitoring and Diagnostics Market Startups Ecosystem
    1. Entrepreneurial Activity
    2. Year-on-Year Funding Received
    3. Funding Received by Top Companies
    4. Key Investors Active in the Market
    5. Series Wise Funding Received
      1. Seed Funding
      2. Angel Investing
      3. Venture Capitalist (VC) Funding
      4. Others
  6. Global Cardiac AI Monitoring and Diagnostics Market Trends & Insights
  7. Global Cardiac AI Monitoring and Diagnostics Market Dynamics
    1. Drivers
    2. Challenges
  8. Global Cardiac AI Monitoring and Diagnostics Market Hotspot & Opportunities
  9. Global Cardiac AI Monitoring and Diagnostics Market Policies & Regulations
  10. Global Cardiac AI Monitoring and Diagnostics Market Supply Chain Analysis
  11. Global Cardiac AI Monitoring and Diagnostics Market Analysis, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
        1. Software- Market Size & Forecast 2019-2030, USD Million
        2. Hardware- Market Size & Forecast 2019-2030, USD Million
      2. By Type
        1. Cardiac Diagnostics- Market Size & Forecast 2019-2030, USD Million
          1. Cardiac Imaging- Market Size & Forecast 2019-2030, USD Million
          2. Electrocardiography-Based (ECG-Based) Diagnostics- Market Size & Forecast 2019-2030, USD Million
          3. Others (Blood Biomarker Analysis, Cardiac Stress Testing, etc.) - Market Size & Forecast 2019-2030, USD Million
        2. Cardiac Monitoring- Market Size & Forecast 2019-2030, USD Million
      3. By Indication
        1. Hypertension (High Blood Pressure)- Market Size & Forecast 2019-2030, USD Million
        2. Coronary Artery Disease (CAD)- Market Size & Forecast 2019-2030, USD Million
        3. Arrhythmias- Market Size & Forecast 2019-2030, USD Million
        4. Cardiomyopathies- Market Size & Forecast 2019-2030, USD Million
        5. Others (Valvular Heart Disease, Peripheral Artery Disease (PAD), etc.) - Market Size & Forecast 2019-2030, USD Million
      4. By End-User
        1. Hospitals - Market Size & Forecast 2019-2030, USD Million
        2. Diagnostic Centers- Market Size & Forecast 2019-2030, USD Million
        3. Specialty Cardiology Clinics- Market Size & Forecast 2019-2030, USD Million
        4. Ambulatory Surgical Centers- Market Size & Forecast 2019-2030, USD Million
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      6. By Company
        1. Competition Characteristics
        2. Market Share & Analysis
  12. North America Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product - Market Size & Forecast 2019-2030, USD Million
      2. By Type - Market Size & Forecast 2019-2030, USD Million
      3. By Indication - Market Size & Forecast 2019-2030, USD Million
      4. By End-User - Market Size & Forecast 2019-2030, USD Million
      5. By Country
        1. The US
        2.  Canada
        3.  Mexico
    3. The US Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    4. Canada Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    5. Mexico Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
  13. South America Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product - Market Size & Forecast 2019-2030, USD Million
      2. By Type - Market Size & Forecast 2019-2030, USD Million
      3. By Indication - Market Size & Forecast 2019-2030, USD Million
      4. By End-User - Market Size & Forecast 2019-2030, USD Million
      5. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
  14. Europe Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product - Market Size & Forecast 2019-2030, USD Million
      2. By Type - Market Size & Forecast 2019-2030, USD Million
      3. By Indication - Market Size & Forecast 2019-2030, USD Million
      4. By End-User - Market Size & Forecast 2019-2030, USD Million
      5. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. The UK Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    4. Germany Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    5. France Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    6. Italy Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    7. Spain Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
  15. Middle East & Africa Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product - Market Size & Forecast 2019-2030, USD Million
      2. By Type - Market Size & Forecast 2019-2030, USD Million
      3. By Indication - Market Size & Forecast 2019-2030, USD Million
      4. By End-User - Market Size & Forecast 2019-2030, USD Million
      5. By Country
        1. GCC
        2. South Africa
        3. Rest of Middle East & Africa
    3. GCC Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    4. South Africa Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
  16.  Asia Pacific Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product - Market Size & Forecast 2019-2030, USD Million
      2. By Type - Market Size & Forecast 2019-2030, USD Million
      3. By Indication - Market Size & Forecast 2019-2030, USD Million
      4. By End-User - Market Size & Forecast 2019-2030, USD Million
      5. By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
    3. China Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    4. India Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    5. Japan Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    6. Australia Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
    7. South Korea Cardiac AI Monitoring and Diagnostics Market Outlook, 2019-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Type - Market Size & Forecast 2019-2030, USD Million
        2. By Indication - Market Size & Forecast 2019-2030, USD Million
  17. Competition Outlook
    1. Company Profiles
      1. HeartVista, Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Siemens Healthineers AG
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. RSIP Vision
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Ultromics Limited.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Tempus Labs, Inc. 
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Cardiologs Technologies
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Cleerly, Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. AliveCor, Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Aidoc Medical Ltd.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Boston Scientific Corporation
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. CathWork Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. HeartFlow, Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. iRhythm Technologies, Inc.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Nano-x Imaging Ltd.
        1. Business Description
        2. Technology Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. Others
  18. Disclaimer


Cardiac AI Monitoring and Diagnostics Market Segmentation